Stocksigma LogoStocksigma Logo

Bharat Parenterals Proposes ₹139 Crore Preferential Issue and Enhanced Investment Limits

Bharat Parenterals scheduled an EGM for 23rd Oct'26 to approve raising up to ₹139.00 crore via a preferential issue of 9,12,759 equity shares at ₹1,522.85

Bharat Parenterals Proposes ₹139 Crore Preferential Issue and Enhanced Investment Limits

Bharat Parenterals Ltd · Extra Ordinary General Meeting · 01 Oct 2026, 11:09 pm

Bharat Parenterals Proposes ₹139 Crore Preferential Issue and Enhanced Investment Limits Bharat Parenterals scheduled an EGM for 23rd Oct'26 to approve raising up to ₹139.00 crore via a preferential issue of 9,12,759 equity shares at ₹1,522.85 per share to non-promoter institutional and individual investors, including WhiteOak Capital entities. Proceeds will primarily fund investments in subsidiaries (up to ₹135.00 crore) and general corporate purposes. The issue will dilute promoter holding from 67.20% to 59.35%. Additionally, the company seeks shareholder approval to enhance its investment, loan, guarantee, and security limits under Section 186 up to ₹140.00 crore.

Original exchange filing (PDF)

More announcements from Bharat Parenterals Ltd

All Bharat Parenterals Ltd announcements